Hunter C Smith - Net Worth and Insider Trading
Hunter C Smith Net Worth
The estimated net worth of Hunter C Smith is at least $5 Million dollars as of 2024-12-27. Hunter C Smith is the CFO of Rhythm Pharmaceuticals Inc and owns about 97,939 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $5 Million. Details can be seen in Hunter C Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hunter C Smith has not made any transactions after 2024-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hunter C Smith
Hunter C Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hunter C Smith owns 3 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , Genesee & Wyoming Inc (GWR) , and Spyre Therapeutics Inc (SYRE) .
Click here to see the complete history of Hunter C Smith’s form 4 insider trades.
Insider Ownership Summary of Hunter C Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2024-03-19 | CFO and Treasurer |
| GWR | Genesee & Wyoming Inc | 2019-12-30 | director |
| SYRE | Spyre Therapeutics Inc | 2021-11-12 | director |
Hunter C Smith Latest Holdings Summary
Hunter C Smith currently owns a total of 1 stock. Hunter C Smith owns 97,939 shares of Rhythm Pharmaceuticals Inc (RYTM) as of March 19, 2024, with a value of $5 Million.
Latest Holdings of Hunter C Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2024-03-19 | 97,939 | 55.54 | 5,439,042 |
Holding Weightings of Hunter C Smith
Hunter C Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Hunter C Smith has made a total of 11 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 15,515 shares on March 19, 2024, which brought Hunter C Smith around $608,498.
Insider Trading History of Hunter C Smith
- 1
Hunter C Smith Trading Performance
Hunter C Smith Ownership Network
Hunter C Smith Owned Company Details
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Hunter C Smith is the CFO and Treasurer of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include EVP & Head of North America Jennifer Chien , Chief Technical Officer Joseph Shulman , and Chief Human Resources Officer Pamela J. Cramer .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Hunter C Smith made 6 insider transaction in Rhythm Pharmaceuticals Inc (RYTM) with a net sale of 69,049. Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 184,943 shares made by Joseph Shulman , a net sale of 145,755 shares made by Jennifer Chien , and a net sale of 85,162 shares made by Pamela J. Cramer .
In summary, during the past 3 months, insiders sold 89,517 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 89,517 shares. During the past 18 months, 672,183 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 672,183 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
Hunter C Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Hunter C Smith. You might contact Hunter C Smith via mailing address: C/o Genesee & Wyoming Inc., 20 West Avenue, Darien Ct 06820.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
